Biomarkers and Oncolytic Viruses in Solid Tumors & Heme Malignancies, hosted by Oncolytics Biotech

The event will feature presentations by management and key opinion leader Dirk Arnold MD, PhD (Executive Board Member of ESMO & Chief of Oncology at Asklepios Klinik Altona), who will discuss biomarkers, their importance in trials, their influence on large pharma and their impact on both commercial viability and a clinical setting.